Company Filing History:
2 out of 15 
1 out of 5 
1 out of 1 
Years Active: 1990-2020
Title: Innovator Spotlight: Silvia Werner
Introduction
Silvia Werner, a pioneering inventor based in Kahl, Germany, has made significant contributions to the fields of synthetic chemistry and pharmaceutical production. With a robust portfolio of six patents, her work has been instrumental in enhancing the efficiency and purity of chemical synthesis processes.
Latest Patents
Among her latest innovations, one prominent patent is focused on "Systems and methods for producing synthetic hypericin." This invention outlines improved systems and methods for producing synthetic hypericin at high volume and high purity. Notably, the process involves a continuous flow micro-reactor for the irradiation step, resulting in a synthetic yield of 30-100% of the dry product. Another critical patent is related to "Methods of making onapristone intermediates," which provides innovative methods and systems for synthesizing key intermediates for onapristone. This method incorporates the use of a narrow band frequency light source for the photoconversion of synthesis intermediates.
Career Highlights
Silvia has built a distinguished career collaborating with leading companies in the biopharmaceutical sector, notably Soligenix, Inc. and Context Biopharma Inc. Her work not only underscores her expertise in chemical synthesis but also highlights her role in advancing pharmaceutical innovations that can potentially improve therapeutic options for patients.
Collaborations
Throughout her career, Silvia has worked alongside talented professionals, including her coworkers Holger Rauter and Rasappa Arumugham. These collaborations have undoubtedly enhanced her research and contributed to her success as an inventor.
Conclusion
Silvia Werner exemplifies the impact of innovative thinking in the realm of chemistry and pharmaceuticals. Her patents demonstrate a commitment to improving production processes and contributing to advancements in medicine. As her work progresses, she continues to be a significant figure in the landscape of scientific innovation.